Skip to main content

Medications Still Effective for Treating ADHD in Children

Medically reviewed by Carmen Pope, BPharm. Last updated on April 16, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, April 16, 2024 -- Medication therapy remains an important treatment for children with attention-deficit/hyperactivity disorder (ADHD), according to a review published online March 25 in Pediatrics.

Bradley S. Peterson, M.D., from the Institute for the Developing Mind at Children’s Hospital Los Angeles, and colleagues conducted a systematic literature review to identify effective treatment of ADHD.

Based on 312 included studies, treatments were classified as medication, psychosocial interventions, parent support, nutrition and supplements, neurofeedback, neurostimulation, physical exercise, complementary medicine, school interventions, and provider approaches. ADHD symptoms were improved with several treatments, although medications had the strongest evidence base for improving outcomes, including disruptive behaviors and broadband measures. However, medications were associated with adverse events.

"The paucity of head-to-head studies comparing treatments precludes research-based recommendations regarding which is likely to be most helpful and which should be tried first, and decisions need to be based on clinical considerations and patient preferences," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.